Showing 1 to 3 of 3 rows
See Report | Preferred Variant Title | Classification | Condition | Published Date | Version | Criteria Specification | Gene |
|---|---|---|---|---|---|---|---|
| View | NM_004985.4(KRAS):c.101C>T (p.Pro34Leu) | Pathogenic | Noonan syndrome | 2024-10-02 | 3.0 | ClinGen RASopathy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for KRAS Version 2.1.0 | KRAS |
| View | NM_004985.4(KRAS):c.101C>T (p.Pro34Leu) | Pathogenic | Noonan syndrome | 2024-09-26 | 2.0 | ClinGen RASopathy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for KRAS Version 2.1.0 | KRAS |
| View | NM_004985.4(KRAS):c.101C>T (p.Pro34Leu) | Pathogenic | Noonan syndrome | 2024-09-26 | 1.0 | ClinGen RASopathy Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines for KRAS Version 2.1.0 | KRAS |
Showing 1 to 3 of 3 rows